Company Filing History:
Years Active: 1999
Title: Suk Hoon Ha: Innovator in Vaccine Development
Introduction
Suk Hoon Ha is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of vaccine development, particularly in relation to Pseudomonas aeruginosa infections. His innovative work has the potential to impact public health positively.
Latest Patents
Suk Hoon Ha holds a patent for a process for preparing a vaccine against Pseudomonas aeruginosa. This invention involves the use of attenuated Pseudomonas aeruginosa strains, which are isolated and purified to create a safe and effective vaccine. The patent details the use of cell wall proteins with molecular weights ranging from 10,000 to 100,000, which are non-pathogenic and exhibit excellent antibody formation capacity. This vaccine is designed to provide immunization against Pseudomonas aeruginosa infections and demonstrates superior cross-protective efficacy.
Career Highlights
Suk Hoon Ha is associated with Cheiljedang Corp., where he continues to work on innovative solutions in the field of biotechnology. His dedication to research and development has led to advancements in vaccine technology, showcasing his commitment to improving health outcomes.
Collaborations
He collaborates with notable colleagues, including Hyun Su Kim and Wan Je Park, who contribute to his research efforts and enhance the innovation process.
Conclusion
Suk Hoon Ha's work in vaccine development represents a significant advancement in combating Pseudomonas aeruginosa infections. His innovative approach and dedication to research are commendable and highlight the importance of continued innovation in the field of biotechnology.